Unknown

Dataset Information

Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.


ABSTRACT: The development of heme oxygenase (HO) inhibitors, especially those that are isozyme-selective, promises powerful pharmacological tools to elucidate the regulatory characteristics of the HO system. It is already known that HO has cytoprotective properties and may play a role in several disease states, making it an enticing therapeutic target. Traditionally, the metalloporphyrins have been used as competitive HO inhibitors owing to their structural similarity with the substrate, heme. However, given heme's important role in several other proteins (e.g. cytochromes P450, nitric oxide synthase), non-selectivity is an unfortunate side-effect. Reports that azalanstat and other non-porphyrin molecules inhibited HO led to a multi-faceted effort to develop novel compounds as potent, selective inhi

SUBMITTER: Rahman MN 

PROVIDER: S-EPMC3565801 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature